Artemether Injection
- Packing: 1 Ml Ampoule.
- Available Strength : 40 Mg/Ml, 80 Mg/Ml
Description
Product Description: Artemether Injection is a meticulously formulated pharmaceutical solution designed to combat malaria effectively. It contains artemether, an artemisinin derivative known for its rapid action against Plasmodium falciparum, the parasite responsible for severe malaria. Manufactured to the highest quality standards, this injection offers fast and reliable treatment for malaria infections.
Indications and Usage: Artemether Injection is indicated for the treatment of uncomplicated malaria caused by Plasmodium falciparum in patients who are unable to take oral medications or in cases of severe malaria where parenteral therapy is necessary. It is particularly useful in situations where rapid parasite clearance is essential for patient recovery.
Dosage and Administration: The dosage of Artemether Injection varies depending on the patient's age, weight, and the severity of the malaria infection. It is typically administered via intramuscular route under the supervision of a qualified healthcare professional. The dosage regimen may involve multiple injections over several days, as determined by the treating physician.
Dosage Forms and Strengths: Artemether Injection is available as a sterile solution in vials containing specific concentrations of artemether formulated for parenteral administration. Each vial is carefully manufactured to ensure accurate dosing and optimal therapeutic outcomes.
Contraindications: This product is contraindicated in patients with a known hypersensitivity to artemisinin derivatives or any of the excipients. It should not be used in patients with a history of neurological disorders or severe hepatic impairment. Additionally, it is contraindicated in pregnant women in the first trimester.
Warnings and Precautions: Healthcare providers should exercise caution when prescribing Artemether Injection to patients with a history of cardiac arrhythmias or electrolyte imbalances. Rarely, serious adverse effects such as neurotoxicity or cardiotoxicity may occur. Patients should be monitored closely for signs of these adverse effects during therapy.
Adverse Reactions/Side Effects: Common adverse reactions associated with Artemether Injection include nausea, vomiting, and injection site reactions. Rarely, serious adverse effects such as neurotoxicity, cardiotoxicity, or hemolysis may occur. Patients should be advised to report any unusual symptoms promptly.
Drug Interactions: Concomitant use of Artemether Injection with other antimalarial drugs, particularly those known to prolong the QT interval, may increase the risk of adverse effects or alter the pharmacokinetics of artemether. Healthcare providers should review the patient's medication profile carefully to avoid potential drug interactions.
Use In Specific Populations Description: Safety and efficacy of Artemether Injection in pediatric patients, pregnant women, and nursing mothers have not been established conclusively. Healthcare providers should assess the potential risks and benefits before prescribing this medication in these populations.
How Supplied/Storage and Handling: Artemether Injection is supplied as a sterile solution in vials for parenteral administration. It should be stored at controlled room temperature away from light and moisture. Care should be taken to avoid freezing or excessive heat exposure. Unused portions should be discarded according to standard procedures for biohazardous waste.
